Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire healthfinch, a company that enhances EMR workflows through automation and analytics. This acquisition aims to strengthen Health Catalyst's Population Health portfolio, previously bolstered by the Able Health acquisition. The healthfinch technology will be integrated into Health Catalyst’s Data Operating System, providing actionable insights and improving patient care efficiency. The transaction is expected to close in Q3 2020 and will be funded through a mix of stock and cash.
Health Catalyst (Nasdaq: HCAT) announced its participation in the COVID-19 Evidence Accelerator, a public-private partnership aimed at enhancing the understanding of COVID-19 using real-world data. The company will contribute insights from its COVID-19 National Registry, which includes data from over 64,000 patients and 500,000 with COVID-related symptoms. These efforts are intended to improve treatment outcomes and inform regulatory decisions. Health Catalyst aims to leverage its data and analytics expertise to help healthcare organizations better diagnose and manage COVID-19.
Health Catalyst, a leader in data and analytics for healthcare, announced their participation in two upcoming investor conferences. CEO Dan Burton will present at the William Blair 40th Annual Growth Stock Conference on June 10, 2020, at 1:20 p.m. CST, while CFO Patrick Nelli will speak at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 11:20 a.m. EST. The company supports healthcare organizations in making data-informed decisions, leveraging insights from over 100 million patient records.
Health Catalyst (Nasdaq: HCAT) reported its Q1 2020 financial results, revealing a 28% increase in total revenue, reaching $45.1 million compared to $35.2 million in Q1 2019. Technology revenue grew by 23% to $24.7 million, and professional services revenue surged 36% to $20.4 million. Despite the revenue growth, the company faced a net loss of $17.5 million, a 27% increase from the previous year. Adjusted EBITDA improved by 11% year-over-year, indicating resilience amid the COVID-19 pandemic. Health Catalyst remains committed to supporting healthcare organizations during these challenging times.
Health Catalyst (HCAT) announced the appointment of Mark Templeton to its Board and the nominating and corporate governance committee, effective June 15, 2020. Templeton, former CEO of DigitalOcean, replaces Promod Haque after his term concludes at the annual stockholders meeting on June 12, 2020. Templeton brings over 20 years of experience, including 14 years as Citrix's CEO, where he significantly expanded the company. Dan Burton, CEO of Health Catalyst, expressed confidence in Templeton's capabilities to drive growth and support the company's mission to improve healthcare through data-informed decisions.
Summary not available.